Falbikitug Biosimilar - Research Grade

Human

LIFï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P15018

Blue ice

Leukemia inhibitory factor (LIF) is an IL-6-family cytokine implicated in stem-cell maintenance, immune regulation, and tumor progression. Targeting LIF, this research-grade anti-human recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of falbikitug supplied strictly for research use only (RUO). Manufactured under rigorous in vivo standards, the ultra-pure, low-endotoxin preparation is available in scalable milligram (mg) to gram (g) quantities to support heavy-usage, high-throughput laboratories. It is well suited to cytokine neutralization and blocking assays, in vitro signaling and screening studies, in vivo tumor and inflammation models, and biologics characterization, functioning as a consistent LIF-directed control reagent.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks